Who is sponsoring NCT06310083?

NCT06310083 is sponsored by Ahmed Nabil Selim.

What drugs are being tested in NCT06310083?

Interventions in NCT06310083: Submucosal Resection Turbinoplasty Versus Partial Inferior Turbinectomy.

What condition does NCT06310083 study?

NCT06310083 studies Turbinate; Hypertrophy Mucous Membrane.

Is NCT06310083 still recruiting?

NCT06310083 is currently completed. Last updated 15 March 2024.

Last reviewed 2024-03-15 · How we verify

NCT06310083

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Endoscopic Submucosal Resection Turbinoplasty VS Turbinectomy

Completed NA Last updated 15 March 2024

What this trial tests

NA trial testing Submucosal Resection Turbinoplasty Versus Partial Inferior Turbinectomy in Turbinate; Hypertrophy Mucous Membrane in 40 participants. Completed in 31 January 2024.

Timeline

1 February 2023

Primary endpoint
31 January 2024

31 January 2024

Quick facts

Lead sponsor	Ahmed Nabil Selim
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	treatment
Enrollment	40
Start date	1 February 2023
Primary completion	31 January 2024
Estimated completion	31 January 2024
Sites	1 location across Egypt

Drugs / interventions tested

Submucosal Resection Turbinoplasty Versus Partial Inferior Turbinectomy

Conditions studied

Turbinate; Hypertrophy Mucous Membrane — all drugs for Turbinate; Hypertrophy Mucous Membrane →

Sponsor

Ahmed Nabil Selim

Who can join

Adults 18 to 45, any sex, with Turbinate; Hypertrophy Mucous Membrane. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of our study is to compare endoscopic submucosal resection Turbinoplasty and partial inferior turbinectomy regarding clinical and radiological evaluation and its possible complications in the treatment of Chronic inferior turbinate hypertrophy.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Endoscopic Submucosal Resection Turbinoplasty and Partial Inferior Turbinectomy for Management of Inferior Turbinate Hypertrophy: A Randomized Clinical Trial.
Easa SH, Farghaly TM, Elswaby ESS, Selim A. · · 2024 · PMID 39559133 · DOI 10.1007/s12070-024-04926-y

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06310083 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ahmed Nabil Selim
Last refreshed: 15 March 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06310083.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing